Publication | Closed Access

Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy

OncologyBenzydamine HydrochlorideRadiation TherapyNeck Cancer PatientsPharmacologyPharmacotherapyHead And Neck CancerOral MucositisNeck OncologyMedicineRadiation OncologyCancer ResearchOral Cancer